Nitroglycerin as a hypotensive drug during general anesthesia

Area of Science:

• Anesthesiology
• Cardiovascular Pharmacology
• Surgical Hemodynamics

Background:

• Intraoperative hypotension is induced to minimize blood loss during surgery.
• Nitroglycerin (TNG) and nitroprusside (SNP) are vasodilators used for controlled hypotension.
• Comparative efficacy and safety data between TNG and SNP are crucial for clinical decision-making.

Purpose of the Study:

• To compare the effects of nitroglycerin (TNG) and nitroprusside (SNP) on circulatory variables and oxygenation during induced hypotension.
• To evaluate the safety and efficacy of TNG versus SNP in reducing intraoperative blood loss.
• To assess the potential superiority of TNG over SNP as a hypotensive agent.

Main Methods:

• A comparative study involving 91 anesthetized patients undergoing induced hypotension.
• Infusions of either nitroglycerin (TNG) or nitroprusside (SNP) were administered.
• Circulatory variables, arterial partial pressure of oxygen (PaO2), and electrocardiographic changes were monitored.

Main Results:

• At comparable systolic blood pressure, TNG resulted in significantly higher mean and diastolic arterial blood pressures.
• Eighteen patients receiving SNP showed electrocardiographic changes indicative of ischemia; none occurred with TNG.
• Both TNG and SNP significantly reduced PaO2 and rate-pressure product, with no adverse events reported for TNG.

Conclusions:

• Nitroglycerin (TNG) is an effective agent for inducing hypotension during surgery.
• TNG appears to be a safer alternative to nitroprusside (SNP) due to a lower incidence of ischemic events.
• TNG may offer advantages over existing hypotensive agents for reducing intraoperative blood loss.